DCW Limited (DCW) Fair Value & Analysis
Basic Materials · IN · Market cap ₹14.2B
Fair value as of: Jun 29, 2026
Analysis
DCW Limited (DCW) currently trades at ₹48.19, while our model-based Fair Value estimate is ₹17.44 — implying the stock looks roughly 63.8% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
DCW Limited engages in the manufacture and sale of heavy chemical products in India. The company offers specialty chemicals, including chlorinated poly vinyl chloride, synthetic iron oxide pigment, and synthetic rutile; intermediate chemicals comprising sodium bicarbonate, hydrochloric acid, liquid chlorine, trichloroethylene, perchloroethylene, ferric chloride, sodium hypochlorite, and ammonium bicarbonate; and commodity chemicals, such as soda ash, caustic soda, and poly vinyl chloride. Its products are used as key ingredients for the manufacturers of agricultural products, detergents, food, pharmaceuticals, pigments, fertilizers, alumina, and other industrial products. The company also exports its products to the United States, Europe, Japan, Malaysia, and the Netherlands. The company was formerly known as Dhrangadhra Chemical Works Limited. DCW Limited was founded in 1925 and is headquartered in Mumbai, India.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is DCW Limited (DCW) undervalued?
What is the fair value of DCW?
What is the quality score of DCW?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.